Global Clinical Next Generation Sequencing (NGS) Supply, Demand and Key Producers, 2023-2029
The global Clinical Next Generation Sequencing (NGS) market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Clinical Next Generation Sequencing (NGS) demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Clinical Next Generation Sequencing (NGS), and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Clinical Next Generation Sequencing (NGS) that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Clinical Next Generation Sequencing (NGS) total market, 2018-2029, (USD Million)
Global Clinical Next Generation Sequencing (NGS) total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Clinical Next Generation Sequencing (NGS) total market, key domestic companies and share, (USD Million)
Global Clinical Next Generation Sequencing (NGS) revenue by player and market share 2018-2023, (USD Million)
Global Clinical Next Generation Sequencing (NGS) total market by Type, CAGR, 2018-2029, (USD Million)
Global Clinical Next Generation Sequencing (NGS) total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Clinical Next Generation Sequencing (NGS) market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Agilent Technologies, Illumina, Thermo Fisher Scientific, Eurofins Scientific, BGI Group, Qiagen, Roche Diagnostics, Bio-Rad and Congenica, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Clinical Next Generation Sequencing (NGS) market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Clinical Next Generation Sequencing (NGS) Market, By Region:
1. How big is the global Clinical Next Generation Sequencing (NGS) market?
2. What is the demand of the global Clinical Next Generation Sequencing (NGS) market?
3. What is the year over year growth of the global Clinical Next Generation Sequencing (NGS) market?
4. What is the total value of the global Clinical Next Generation Sequencing (NGS) market?
5. Who are the major players in the global Clinical Next Generation Sequencing (NGS) market?
6. What are the growth factors driving the market demand?
This report studies the global Clinical Next Generation Sequencing (NGS) demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Clinical Next Generation Sequencing (NGS), and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Clinical Next Generation Sequencing (NGS) that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Clinical Next Generation Sequencing (NGS) total market, 2018-2029, (USD Million)
Global Clinical Next Generation Sequencing (NGS) total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Clinical Next Generation Sequencing (NGS) total market, key domestic companies and share, (USD Million)
Global Clinical Next Generation Sequencing (NGS) revenue by player and market share 2018-2023, (USD Million)
Global Clinical Next Generation Sequencing (NGS) total market by Type, CAGR, 2018-2029, (USD Million)
Global Clinical Next Generation Sequencing (NGS) total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Clinical Next Generation Sequencing (NGS) market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Agilent Technologies, Illumina, Thermo Fisher Scientific, Eurofins Scientific, BGI Group, Qiagen, Roche Diagnostics, Bio-Rad and Congenica, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Clinical Next Generation Sequencing (NGS) market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Clinical Next Generation Sequencing (NGS) Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Sequencing by Synthesis (SBS)
- Nanopore Sequencing
- Single-Molecule Real-Time (SMRT) Sequencing
- Others
- Diagnostics
- Drug Discovery & Designing
- Medical Research
- Others
- Agilent Technologies
- Illumina
- Thermo Fisher Scientific
- Eurofins Scientific
- BGI Group
- Qiagen
- Roche Diagnostics
- Bio-Rad
- Congenica
- Theragen Etex
- PerkinElmer
- Partek
- Oxford Nanopore Technologies
- Pacific Biosciences of California
- Golden Helix
- BioDatomics
- PierianDx
- DNAStar
1. How big is the global Clinical Next Generation Sequencing (NGS) market?
2. What is the demand of the global Clinical Next Generation Sequencing (NGS) market?
3. What is the year over year growth of the global Clinical Next Generation Sequencing (NGS) market?
4. What is the total value of the global Clinical Next Generation Sequencing (NGS) market?
5. Who are the major players in the global Clinical Next Generation Sequencing (NGS) market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Clinical Next Generation Sequencing (NGS) Introduction
1.2 World Clinical Next Generation Sequencing (NGS) Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Clinical Next Generation Sequencing (NGS) Total Market by Region (by Headquarter Location)
1.3.1 World Clinical Next Generation Sequencing (NGS) Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Clinical Next Generation Sequencing (NGS) Market Size (2018-2029)
1.3.3 China Clinical Next Generation Sequencing (NGS) Market Size (2018-2029)
1.3.4 Europe Clinical Next Generation Sequencing (NGS) Market Size (2018-2029)
1.3.5 Japan Clinical Next Generation Sequencing (NGS) Market Size (2018-2029)
1.3.6 South Korea Clinical Next Generation Sequencing (NGS) Market Size (2018-2029)
1.3.7 ASEAN Clinical Next Generation Sequencing (NGS) Market Size (2018-2029)
1.3.8 India Clinical Next Generation Sequencing (NGS) Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Clinical Next Generation Sequencing (NGS) Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Clinical Next Generation Sequencing (NGS) Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029)
2.2 World Clinical Next Generation Sequencing (NGS) Consumption Value by Region
2.2.1 World Clinical Next Generation Sequencing (NGS) Consumption Value by Region (2018-2023)
2.2.2 World Clinical Next Generation Sequencing (NGS) Consumption Value Forecast by Region (2024-2029)
2.3 United States Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029)
2.4 China Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029)
2.5 Europe Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029)
2.6 Japan Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029)
2.7 South Korea Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029)
2.8 ASEAN Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029)
2.9 India Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029)
3 WORLD CLINICAL NEXT GENERATION SEQUENCING (NGS) COMPANIES COMPETITIVE ANALYSIS
3.1 World Clinical Next Generation Sequencing (NGS) Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Clinical Next Generation Sequencing (NGS) Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Clinical Next Generation Sequencing (NGS) in 2022
3.2.3 Global Concentration Ratios (CR8) for Clinical Next Generation Sequencing (NGS) in 2022
3.3 Clinical Next Generation Sequencing (NGS) Company Evaluation Quadrant
3.4 Clinical Next Generation Sequencing (NGS) Market: Overall Company Footprint Analysis
3.4.1 Clinical Next Generation Sequencing (NGS) Market: Region Footprint
3.4.2 Clinical Next Generation Sequencing (NGS) Market: Company Product Type Footprint
3.4.3 Clinical Next Generation Sequencing (NGS) Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Clinical Next Generation Sequencing (NGS) Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Clinical Next Generation Sequencing (NGS) Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Clinical Next Generation Sequencing (NGS) Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Clinical Next Generation Sequencing (NGS) Consumption Value Comparison
4.2.1 United States VS China: Clinical Next Generation Sequencing (NGS) Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Clinical Next Generation Sequencing (NGS) Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Clinical Next Generation Sequencing (NGS) Companies and Market Share, 2018-2023
4.3.1 United States Based Clinical Next Generation Sequencing (NGS) Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Clinical Next Generation Sequencing (NGS) Revenue, (2018-2023)
4.4 China Based Companies Clinical Next Generation Sequencing (NGS) Revenue and Market Share, 2018-2023
4.4.1 China Based Clinical Next Generation Sequencing (NGS) Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Clinical Next Generation Sequencing (NGS) Revenue, (2018-2023)
4.5 Rest of World Based Clinical Next Generation Sequencing (NGS) Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Clinical Next Generation Sequencing (NGS) Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Clinical Next Generation Sequencing (NGS) Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Clinical Next Generation Sequencing (NGS) Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Sequencing by Synthesis (SBS)
5.2.2 Nanopore Sequencing
5.2.3 Single-Molecule Real-Time (SMRT) Sequencing
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Clinical Next Generation Sequencing (NGS) Market Size by Type (2018-2023)
5.3.2 World Clinical Next Generation Sequencing (NGS) Market Size by Type (2024-2029)
5.3.3 World Clinical Next Generation Sequencing (NGS) Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Clinical Next Generation Sequencing (NGS) Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Diagnostics
6.2.2 Drug Discovery & Designing
6.2.3 Medical Research
6.2.4 Others
6.2.5 Others
6.3 Market Segment by Application
6.3.1 World Clinical Next Generation Sequencing (NGS) Market Size by Application (2018-2023)
6.3.2 World Clinical Next Generation Sequencing (NGS) Market Size by Application (2024-2029)
6.3.3 World Clinical Next Generation Sequencing (NGS) Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Agilent Technologies
7.1.1 Agilent Technologies Details
7.1.2 Agilent Technologies Major Business
7.1.3 Agilent Technologies Clinical Next Generation Sequencing (NGS) Product and Services
7.1.4 Agilent Technologies Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Agilent Technologies Recent Developments/Updates
7.1.6 Agilent Technologies Competitive Strengths & Weaknesses
7.2 Illumina
7.2.1 Illumina Details
7.2.2 Illumina Major Business
7.2.3 Illumina Clinical Next Generation Sequencing (NGS) Product and Services
7.2.4 Illumina Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Illumina Recent Developments/Updates
7.2.6 Illumina Competitive Strengths & Weaknesses
7.3 Thermo Fisher Scientific
7.3.1 Thermo Fisher Scientific Details
7.3.2 Thermo Fisher Scientific Major Business
7.3.3 Thermo Fisher Scientific Clinical Next Generation Sequencing (NGS) Product and Services
7.3.4 Thermo Fisher Scientific Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Thermo Fisher Scientific Recent Developments/Updates
7.3.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.4 Eurofins Scientific
7.4.1 Eurofins Scientific Details
7.4.2 Eurofins Scientific Major Business
7.4.3 Eurofins Scientific Clinical Next Generation Sequencing (NGS) Product and Services
7.4.4 Eurofins Scientific Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Eurofins Scientific Recent Developments/Updates
7.4.6 Eurofins Scientific Competitive Strengths & Weaknesses
7.5 BGI Group
7.5.1 BGI Group Details
7.5.2 BGI Group Major Business
7.5.3 BGI Group Clinical Next Generation Sequencing (NGS) Product and Services
7.5.4 BGI Group Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 BGI Group Recent Developments/Updates
7.5.6 BGI Group Competitive Strengths & Weaknesses
7.6 Qiagen
7.6.1 Qiagen Details
7.6.2 Qiagen Major Business
7.6.3 Qiagen Clinical Next Generation Sequencing (NGS) Product and Services
7.6.4 Qiagen Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Qiagen Recent Developments/Updates
7.6.6 Qiagen Competitive Strengths & Weaknesses
7.7 Roche Diagnostics
7.7.1 Roche Diagnostics Details
7.7.2 Roche Diagnostics Major Business
7.7.3 Roche Diagnostics Clinical Next Generation Sequencing (NGS) Product and Services
7.7.4 Roche Diagnostics Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Roche Diagnostics Recent Developments/Updates
7.7.6 Roche Diagnostics Competitive Strengths & Weaknesses
7.8 Bio-Rad
7.8.1 Bio-Rad Details
7.8.2 Bio-Rad Major Business
7.8.3 Bio-Rad Clinical Next Generation Sequencing (NGS) Product and Services
7.8.4 Bio-Rad Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Bio-Rad Recent Developments/Updates
7.8.6 Bio-Rad Competitive Strengths & Weaknesses
7.9 Congenica
7.9.1 Congenica Details
7.9.2 Congenica Major Business
7.9.3 Congenica Clinical Next Generation Sequencing (NGS) Product and Services
7.9.4 Congenica Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Congenica Recent Developments/Updates
7.9.6 Congenica Competitive Strengths & Weaknesses
7.10 Theragen Etex
7.10.1 Theragen Etex Details
7.10.2 Theragen Etex Major Business
7.10.3 Theragen Etex Clinical Next Generation Sequencing (NGS) Product and Services
7.10.4 Theragen Etex Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Theragen Etex Recent Developments/Updates
7.10.6 Theragen Etex Competitive Strengths & Weaknesses
7.11 PerkinElmer
7.11.1 PerkinElmer Details
7.11.2 PerkinElmer Major Business
7.11.3 PerkinElmer Clinical Next Generation Sequencing (NGS) Product and Services
7.11.4 PerkinElmer Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 PerkinElmer Recent Developments/Updates
7.11.6 PerkinElmer Competitive Strengths & Weaknesses
7.12 Partek
7.12.1 Partek Details
7.12.2 Partek Major Business
7.12.3 Partek Clinical Next Generation Sequencing (NGS) Product and Services
7.12.4 Partek Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Partek Recent Developments/Updates
7.12.6 Partek Competitive Strengths & Weaknesses
7.13 Oxford Nanopore Technologies
7.13.1 Oxford Nanopore Technologies Details
7.13.2 Oxford Nanopore Technologies Major Business
7.13.3 Oxford Nanopore Technologies Clinical Next Generation Sequencing (NGS) Product and Services
7.13.4 Oxford Nanopore Technologies Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Oxford Nanopore Technologies Recent Developments/Updates
7.13.6 Oxford Nanopore Technologies Competitive Strengths & Weaknesses
7.14 Pacific Biosciences of California
7.14.1 Pacific Biosciences of California Details
7.14.2 Pacific Biosciences of California Major Business
7.14.3 Pacific Biosciences of California Clinical Next Generation Sequencing (NGS) Product and Services
7.14.4 Pacific Biosciences of California Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Pacific Biosciences of California Recent Developments/Updates
7.14.6 Pacific Biosciences of California Competitive Strengths & Weaknesses
7.15 Golden Helix
7.15.1 Golden Helix Details
7.15.2 Golden Helix Major Business
7.15.3 Golden Helix Clinical Next Generation Sequencing (NGS) Product and Services
7.15.4 Golden Helix Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Golden Helix Recent Developments/Updates
7.15.6 Golden Helix Competitive Strengths & Weaknesses
7.16 BioDatomics
7.16.1 BioDatomics Details
7.16.2 BioDatomics Major Business
7.16.3 BioDatomics Clinical Next Generation Sequencing (NGS) Product and Services
7.16.4 BioDatomics Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 BioDatomics Recent Developments/Updates
7.16.6 BioDatomics Competitive Strengths & Weaknesses
7.17 PierianDx
7.17.1 PierianDx Details
7.17.2 PierianDx Major Business
7.17.3 PierianDx Clinical Next Generation Sequencing (NGS) Product and Services
7.17.4 PierianDx Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 PierianDx Recent Developments/Updates
7.17.6 PierianDx Competitive Strengths & Weaknesses
7.18 DNAStar
7.18.1 DNAStar Details
7.18.2 DNAStar Major Business
7.18.3 DNAStar Clinical Next Generation Sequencing (NGS) Product and Services
7.18.4 DNAStar Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 DNAStar Recent Developments/Updates
7.18.6 DNAStar Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Clinical Next Generation Sequencing (NGS) Industry Chain
8.2 Clinical Next Generation Sequencing (NGS) Upstream Analysis
8.3 Clinical Next Generation Sequencing (NGS) Midstream Analysis
8.4 Clinical Next Generation Sequencing (NGS) Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Clinical Next Generation Sequencing (NGS) Introduction
1.2 World Clinical Next Generation Sequencing (NGS) Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Clinical Next Generation Sequencing (NGS) Total Market by Region (by Headquarter Location)
1.3.1 World Clinical Next Generation Sequencing (NGS) Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Clinical Next Generation Sequencing (NGS) Market Size (2018-2029)
1.3.3 China Clinical Next Generation Sequencing (NGS) Market Size (2018-2029)
1.3.4 Europe Clinical Next Generation Sequencing (NGS) Market Size (2018-2029)
1.3.5 Japan Clinical Next Generation Sequencing (NGS) Market Size (2018-2029)
1.3.6 South Korea Clinical Next Generation Sequencing (NGS) Market Size (2018-2029)
1.3.7 ASEAN Clinical Next Generation Sequencing (NGS) Market Size (2018-2029)
1.3.8 India Clinical Next Generation Sequencing (NGS) Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Clinical Next Generation Sequencing (NGS) Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Clinical Next Generation Sequencing (NGS) Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029)
2.2 World Clinical Next Generation Sequencing (NGS) Consumption Value by Region
2.2.1 World Clinical Next Generation Sequencing (NGS) Consumption Value by Region (2018-2023)
2.2.2 World Clinical Next Generation Sequencing (NGS) Consumption Value Forecast by Region (2024-2029)
2.3 United States Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029)
2.4 China Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029)
2.5 Europe Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029)
2.6 Japan Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029)
2.7 South Korea Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029)
2.8 ASEAN Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029)
2.9 India Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029)
3 WORLD CLINICAL NEXT GENERATION SEQUENCING (NGS) COMPANIES COMPETITIVE ANALYSIS
3.1 World Clinical Next Generation Sequencing (NGS) Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Clinical Next Generation Sequencing (NGS) Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Clinical Next Generation Sequencing (NGS) in 2022
3.2.3 Global Concentration Ratios (CR8) for Clinical Next Generation Sequencing (NGS) in 2022
3.3 Clinical Next Generation Sequencing (NGS) Company Evaluation Quadrant
3.4 Clinical Next Generation Sequencing (NGS) Market: Overall Company Footprint Analysis
3.4.1 Clinical Next Generation Sequencing (NGS) Market: Region Footprint
3.4.2 Clinical Next Generation Sequencing (NGS) Market: Company Product Type Footprint
3.4.3 Clinical Next Generation Sequencing (NGS) Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Clinical Next Generation Sequencing (NGS) Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Clinical Next Generation Sequencing (NGS) Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Clinical Next Generation Sequencing (NGS) Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Clinical Next Generation Sequencing (NGS) Consumption Value Comparison
4.2.1 United States VS China: Clinical Next Generation Sequencing (NGS) Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Clinical Next Generation Sequencing (NGS) Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Clinical Next Generation Sequencing (NGS) Companies and Market Share, 2018-2023
4.3.1 United States Based Clinical Next Generation Sequencing (NGS) Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Clinical Next Generation Sequencing (NGS) Revenue, (2018-2023)
4.4 China Based Companies Clinical Next Generation Sequencing (NGS) Revenue and Market Share, 2018-2023
4.4.1 China Based Clinical Next Generation Sequencing (NGS) Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Clinical Next Generation Sequencing (NGS) Revenue, (2018-2023)
4.5 Rest of World Based Clinical Next Generation Sequencing (NGS) Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Clinical Next Generation Sequencing (NGS) Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Clinical Next Generation Sequencing (NGS) Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Clinical Next Generation Sequencing (NGS) Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Sequencing by Synthesis (SBS)
5.2.2 Nanopore Sequencing
5.2.3 Single-Molecule Real-Time (SMRT) Sequencing
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Clinical Next Generation Sequencing (NGS) Market Size by Type (2018-2023)
5.3.2 World Clinical Next Generation Sequencing (NGS) Market Size by Type (2024-2029)
5.3.3 World Clinical Next Generation Sequencing (NGS) Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Clinical Next Generation Sequencing (NGS) Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Diagnostics
6.2.2 Drug Discovery & Designing
6.2.3 Medical Research
6.2.4 Others
6.2.5 Others
6.3 Market Segment by Application
6.3.1 World Clinical Next Generation Sequencing (NGS) Market Size by Application (2018-2023)
6.3.2 World Clinical Next Generation Sequencing (NGS) Market Size by Application (2024-2029)
6.3.3 World Clinical Next Generation Sequencing (NGS) Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Agilent Technologies
7.1.1 Agilent Technologies Details
7.1.2 Agilent Technologies Major Business
7.1.3 Agilent Technologies Clinical Next Generation Sequencing (NGS) Product and Services
7.1.4 Agilent Technologies Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Agilent Technologies Recent Developments/Updates
7.1.6 Agilent Technologies Competitive Strengths & Weaknesses
7.2 Illumina
7.2.1 Illumina Details
7.2.2 Illumina Major Business
7.2.3 Illumina Clinical Next Generation Sequencing (NGS) Product and Services
7.2.4 Illumina Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Illumina Recent Developments/Updates
7.2.6 Illumina Competitive Strengths & Weaknesses
7.3 Thermo Fisher Scientific
7.3.1 Thermo Fisher Scientific Details
7.3.2 Thermo Fisher Scientific Major Business
7.3.3 Thermo Fisher Scientific Clinical Next Generation Sequencing (NGS) Product and Services
7.3.4 Thermo Fisher Scientific Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Thermo Fisher Scientific Recent Developments/Updates
7.3.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.4 Eurofins Scientific
7.4.1 Eurofins Scientific Details
7.4.2 Eurofins Scientific Major Business
7.4.3 Eurofins Scientific Clinical Next Generation Sequencing (NGS) Product and Services
7.4.4 Eurofins Scientific Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Eurofins Scientific Recent Developments/Updates
7.4.6 Eurofins Scientific Competitive Strengths & Weaknesses
7.5 BGI Group
7.5.1 BGI Group Details
7.5.2 BGI Group Major Business
7.5.3 BGI Group Clinical Next Generation Sequencing (NGS) Product and Services
7.5.4 BGI Group Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 BGI Group Recent Developments/Updates
7.5.6 BGI Group Competitive Strengths & Weaknesses
7.6 Qiagen
7.6.1 Qiagen Details
7.6.2 Qiagen Major Business
7.6.3 Qiagen Clinical Next Generation Sequencing (NGS) Product and Services
7.6.4 Qiagen Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Qiagen Recent Developments/Updates
7.6.6 Qiagen Competitive Strengths & Weaknesses
7.7 Roche Diagnostics
7.7.1 Roche Diagnostics Details
7.7.2 Roche Diagnostics Major Business
7.7.3 Roche Diagnostics Clinical Next Generation Sequencing (NGS) Product and Services
7.7.4 Roche Diagnostics Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Roche Diagnostics Recent Developments/Updates
7.7.6 Roche Diagnostics Competitive Strengths & Weaknesses
7.8 Bio-Rad
7.8.1 Bio-Rad Details
7.8.2 Bio-Rad Major Business
7.8.3 Bio-Rad Clinical Next Generation Sequencing (NGS) Product and Services
7.8.4 Bio-Rad Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Bio-Rad Recent Developments/Updates
7.8.6 Bio-Rad Competitive Strengths & Weaknesses
7.9 Congenica
7.9.1 Congenica Details
7.9.2 Congenica Major Business
7.9.3 Congenica Clinical Next Generation Sequencing (NGS) Product and Services
7.9.4 Congenica Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Congenica Recent Developments/Updates
7.9.6 Congenica Competitive Strengths & Weaknesses
7.10 Theragen Etex
7.10.1 Theragen Etex Details
7.10.2 Theragen Etex Major Business
7.10.3 Theragen Etex Clinical Next Generation Sequencing (NGS) Product and Services
7.10.4 Theragen Etex Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Theragen Etex Recent Developments/Updates
7.10.6 Theragen Etex Competitive Strengths & Weaknesses
7.11 PerkinElmer
7.11.1 PerkinElmer Details
7.11.2 PerkinElmer Major Business
7.11.3 PerkinElmer Clinical Next Generation Sequencing (NGS) Product and Services
7.11.4 PerkinElmer Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 PerkinElmer Recent Developments/Updates
7.11.6 PerkinElmer Competitive Strengths & Weaknesses
7.12 Partek
7.12.1 Partek Details
7.12.2 Partek Major Business
7.12.3 Partek Clinical Next Generation Sequencing (NGS) Product and Services
7.12.4 Partek Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Partek Recent Developments/Updates
7.12.6 Partek Competitive Strengths & Weaknesses
7.13 Oxford Nanopore Technologies
7.13.1 Oxford Nanopore Technologies Details
7.13.2 Oxford Nanopore Technologies Major Business
7.13.3 Oxford Nanopore Technologies Clinical Next Generation Sequencing (NGS) Product and Services
7.13.4 Oxford Nanopore Technologies Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Oxford Nanopore Technologies Recent Developments/Updates
7.13.6 Oxford Nanopore Technologies Competitive Strengths & Weaknesses
7.14 Pacific Biosciences of California
7.14.1 Pacific Biosciences of California Details
7.14.2 Pacific Biosciences of California Major Business
7.14.3 Pacific Biosciences of California Clinical Next Generation Sequencing (NGS) Product and Services
7.14.4 Pacific Biosciences of California Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Pacific Biosciences of California Recent Developments/Updates
7.14.6 Pacific Biosciences of California Competitive Strengths & Weaknesses
7.15 Golden Helix
7.15.1 Golden Helix Details
7.15.2 Golden Helix Major Business
7.15.3 Golden Helix Clinical Next Generation Sequencing (NGS) Product and Services
7.15.4 Golden Helix Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Golden Helix Recent Developments/Updates
7.15.6 Golden Helix Competitive Strengths & Weaknesses
7.16 BioDatomics
7.16.1 BioDatomics Details
7.16.2 BioDatomics Major Business
7.16.3 BioDatomics Clinical Next Generation Sequencing (NGS) Product and Services
7.16.4 BioDatomics Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 BioDatomics Recent Developments/Updates
7.16.6 BioDatomics Competitive Strengths & Weaknesses
7.17 PierianDx
7.17.1 PierianDx Details
7.17.2 PierianDx Major Business
7.17.3 PierianDx Clinical Next Generation Sequencing (NGS) Product and Services
7.17.4 PierianDx Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 PierianDx Recent Developments/Updates
7.17.6 PierianDx Competitive Strengths & Weaknesses
7.18 DNAStar
7.18.1 DNAStar Details
7.18.2 DNAStar Major Business
7.18.3 DNAStar Clinical Next Generation Sequencing (NGS) Product and Services
7.18.4 DNAStar Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 DNAStar Recent Developments/Updates
7.18.6 DNAStar Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Clinical Next Generation Sequencing (NGS) Industry Chain
8.2 Clinical Next Generation Sequencing (NGS) Upstream Analysis
8.3 Clinical Next Generation Sequencing (NGS) Midstream Analysis
8.4 Clinical Next Generation Sequencing (NGS) Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Clinical Next Generation Sequencing (NGS) Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Clinical Next Generation Sequencing (NGS) Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Clinical Next Generation Sequencing (NGS) Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Clinical Next Generation Sequencing (NGS) Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Clinical Next Generation Sequencing (NGS) Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Clinical Next Generation Sequencing (NGS) Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Clinical Next Generation Sequencing (NGS) Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Clinical Next Generation Sequencing (NGS) Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Clinical Next Generation Sequencing (NGS) Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Clinical Next Generation Sequencing (NGS) Players in 2022
Table 12. World Clinical Next Generation Sequencing (NGS) Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Clinical Next Generation Sequencing (NGS) Company Evaluation Quadrant
Table 14. Head Office of Key Clinical Next Generation Sequencing (NGS) Player
Table 15. Clinical Next Generation Sequencing (NGS) Market: Company Product Type Footprint
Table 16. Clinical Next Generation Sequencing (NGS) Market: Company Product Application Footprint
Table 17. Clinical Next Generation Sequencing (NGS) Mergers & Acquisitions Activity
Table 18. United States VS China Clinical Next Generation Sequencing (NGS) Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Clinical Next Generation Sequencing (NGS) Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Clinical Next Generation Sequencing (NGS) Companies, Headquarters (States, Country)
Table 21. United States Based Companies Clinical Next Generation Sequencing (NGS) Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Clinical Next Generation Sequencing (NGS) Revenue Market Share (2018-2023)
Table 23. China Based Clinical Next Generation Sequencing (NGS) Companies, Headquarters (Province, Country)
Table 24. China Based Companies Clinical Next Generation Sequencing (NGS) Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Clinical Next Generation Sequencing (NGS) Revenue Market Share (2018-2023)
Table 26. Rest of World Based Clinical Next Generation Sequencing (NGS) Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Clinical Next Generation Sequencing (NGS) Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Clinical Next Generation Sequencing (NGS) Revenue Market Share (2018-2023)
Table 29. World Clinical Next Generation Sequencing (NGS) Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Clinical Next Generation Sequencing (NGS) Market Size by Type (2018-2023) & (USD Million)
Table 31. World Clinical Next Generation Sequencing (NGS) Market Size by Type (2024-2029) & (USD Million)
Table 32. World Clinical Next Generation Sequencing (NGS) Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Clinical Next Generation Sequencing (NGS) Market Size by Application (2018-2023) & (USD Million)
Table 34. World Clinical Next Generation Sequencing (NGS) Market Size by Application (2024-2029) & (USD Million)
Table 35. Agilent Technologies Basic Information, Area Served and Competitors
Table 36. Agilent Technologies Major Business
Table 37. Agilent Technologies Clinical Next Generation Sequencing (NGS) Product and Services
Table 38. Agilent Technologies Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Agilent Technologies Recent Developments/Updates
Table 40. Agilent Technologies Competitive Strengths & Weaknesses
Table 41. Illumina Basic Information, Area Served and Competitors
Table 42. Illumina Major Business
Table 43. Illumina Clinical Next Generation Sequencing (NGS) Product and Services
Table 44. Illumina Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Illumina Recent Developments/Updates
Table 46. Illumina Competitive Strengths & Weaknesses
Table 47. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 48. Thermo Fisher Scientific Major Business
Table 49. Thermo Fisher Scientific Clinical Next Generation Sequencing (NGS) Product and Services
Table 50. Thermo Fisher Scientific Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Thermo Fisher Scientific Recent Developments/Updates
Table 52. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 53. Eurofins Scientific Basic Information, Area Served and Competitors
Table 54. Eurofins Scientific Major Business
Table 55. Eurofins Scientific Clinical Next Generation Sequencing (NGS) Product and Services
Table 56. Eurofins Scientific Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Eurofins Scientific Recent Developments/Updates
Table 58. Eurofins Scientific Competitive Strengths & Weaknesses
Table 59. BGI Group Basic Information, Area Served and Competitors
Table 60. BGI Group Major Business
Table 61. BGI Group Clinical Next Generation Sequencing (NGS) Product and Services
Table 62. BGI Group Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. BGI Group Recent Developments/Updates
Table 64. BGI Group Competitive Strengths & Weaknesses
Table 65. Qiagen Basic Information, Area Served and Competitors
Table 66. Qiagen Major Business
Table 67. Qiagen Clinical Next Generation Sequencing (NGS) Product and Services
Table 68. Qiagen Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Qiagen Recent Developments/Updates
Table 70. Qiagen Competitive Strengths & Weaknesses
Table 71. Roche Diagnostics Basic Information, Area Served and Competitors
Table 72. Roche Diagnostics Major Business
Table 73. Roche Diagnostics Clinical Next Generation Sequencing (NGS) Product and Services
Table 74. Roche Diagnostics Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Roche Diagnostics Recent Developments/Updates
Table 76. Roche Diagnostics Competitive Strengths & Weaknesses
Table 77. Bio-Rad Basic Information, Area Served and Competitors
Table 78. Bio-Rad Major Business
Table 79. Bio-Rad Clinical Next Generation Sequencing (NGS) Product and Services
Table 80. Bio-Rad Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Bio-Rad Recent Developments/Updates
Table 82. Bio-Rad Competitive Strengths & Weaknesses
Table 83. Congenica Basic Information, Area Served and Competitors
Table 84. Congenica Major Business
Table 85. Congenica Clinical Next Generation Sequencing (NGS) Product and Services
Table 86. Congenica Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Congenica Recent Developments/Updates
Table 88. Congenica Competitive Strengths & Weaknesses
Table 89. Theragen Etex Basic Information, Area Served and Competitors
Table 90. Theragen Etex Major Business
Table 91. Theragen Etex Clinical Next Generation Sequencing (NGS) Product and Services
Table 92. Theragen Etex Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Theragen Etex Recent Developments/Updates
Table 94. Theragen Etex Competitive Strengths & Weaknesses
Table 95. PerkinElmer Basic Information, Area Served and Competitors
Table 96. PerkinElmer Major Business
Table 97. PerkinElmer Clinical Next Generation Sequencing (NGS) Product and Services
Table 98. PerkinElmer Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. PerkinElmer Recent Developments/Updates
Table 100. PerkinElmer Competitive Strengths & Weaknesses
Table 101. Partek Basic Information, Area Served and Competitors
Table 102. Partek Major Business
Table 103. Partek Clinical Next Generation Sequencing (NGS) Product and Services
Table 104. Partek Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Partek Recent Developments/Updates
Table 106. Partek Competitive Strengths & Weaknesses
Table 107. Oxford Nanopore Technologies Basic Information, Area Served and Competitors
Table 108. Oxford Nanopore Technologies Major Business
Table 109. Oxford Nanopore Technologies Clinical Next Generation Sequencing (NGS) Product and Services
Table 110. Oxford Nanopore Technologies Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Oxford Nanopore Technologies Recent Developments/Updates
Table 112. Oxford Nanopore Technologies Competitive Strengths & Weaknesses
Table 113. Pacific Biosciences of California Basic Information, Area Served and Competitors
Table 114. Pacific Biosciences of California Major Business
Table 115. Pacific Biosciences of California Clinical Next Generation Sequencing (NGS) Product and Services
Table 116. Pacific Biosciences of California Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Pacific Biosciences of California Recent Developments/Updates
Table 118. Pacific Biosciences of California Competitive Strengths & Weaknesses
Table 119. Golden Helix Basic Information, Area Served and Competitors
Table 120. Golden Helix Major Business
Table 121. Golden Helix Clinical Next Generation Sequencing (NGS) Product and Services
Table 122. Golden Helix Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Golden Helix Recent Developments/Updates
Table 124. Golden Helix Competitive Strengths & Weaknesses
Table 125. BioDatomics Basic Information, Area Served and Competitors
Table 126. BioDatomics Major Business
Table 127. BioDatomics Clinical Next Generation Sequencing (NGS) Product and Services
Table 128. BioDatomics Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. BioDatomics Recent Developments/Updates
Table 130. BioDatomics Competitive Strengths & Weaknesses
Table 131. PierianDx Basic Information, Area Served and Competitors
Table 132. PierianDx Major Business
Table 133. PierianDx Clinical Next Generation Sequencing (NGS) Product and Services
Table 134. PierianDx Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. PierianDx Recent Developments/Updates
Table 136. DNAStar Basic Information, Area Served and Competitors
Table 137. DNAStar Major Business
Table 138. DNAStar Clinical Next Generation Sequencing (NGS) Product and Services
Table 139. DNAStar Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 140. Global Key Players of Clinical Next Generation Sequencing (NGS) Upstream (Raw Materials)
Table 141. Clinical Next Generation Sequencing (NGS) Typical Customers
Table 1. World Clinical Next Generation Sequencing (NGS) Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Clinical Next Generation Sequencing (NGS) Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Clinical Next Generation Sequencing (NGS) Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Clinical Next Generation Sequencing (NGS) Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Clinical Next Generation Sequencing (NGS) Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Clinical Next Generation Sequencing (NGS) Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Clinical Next Generation Sequencing (NGS) Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Clinical Next Generation Sequencing (NGS) Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Clinical Next Generation Sequencing (NGS) Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Clinical Next Generation Sequencing (NGS) Players in 2022
Table 12. World Clinical Next Generation Sequencing (NGS) Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Clinical Next Generation Sequencing (NGS) Company Evaluation Quadrant
Table 14. Head Office of Key Clinical Next Generation Sequencing (NGS) Player
Table 15. Clinical Next Generation Sequencing (NGS) Market: Company Product Type Footprint
Table 16. Clinical Next Generation Sequencing (NGS) Market: Company Product Application Footprint
Table 17. Clinical Next Generation Sequencing (NGS) Mergers & Acquisitions Activity
Table 18. United States VS China Clinical Next Generation Sequencing (NGS) Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Clinical Next Generation Sequencing (NGS) Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Clinical Next Generation Sequencing (NGS) Companies, Headquarters (States, Country)
Table 21. United States Based Companies Clinical Next Generation Sequencing (NGS) Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Clinical Next Generation Sequencing (NGS) Revenue Market Share (2018-2023)
Table 23. China Based Clinical Next Generation Sequencing (NGS) Companies, Headquarters (Province, Country)
Table 24. China Based Companies Clinical Next Generation Sequencing (NGS) Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Clinical Next Generation Sequencing (NGS) Revenue Market Share (2018-2023)
Table 26. Rest of World Based Clinical Next Generation Sequencing (NGS) Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Clinical Next Generation Sequencing (NGS) Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Clinical Next Generation Sequencing (NGS) Revenue Market Share (2018-2023)
Table 29. World Clinical Next Generation Sequencing (NGS) Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Clinical Next Generation Sequencing (NGS) Market Size by Type (2018-2023) & (USD Million)
Table 31. World Clinical Next Generation Sequencing (NGS) Market Size by Type (2024-2029) & (USD Million)
Table 32. World Clinical Next Generation Sequencing (NGS) Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Clinical Next Generation Sequencing (NGS) Market Size by Application (2018-2023) & (USD Million)
Table 34. World Clinical Next Generation Sequencing (NGS) Market Size by Application (2024-2029) & (USD Million)
Table 35. Agilent Technologies Basic Information, Area Served and Competitors
Table 36. Agilent Technologies Major Business
Table 37. Agilent Technologies Clinical Next Generation Sequencing (NGS) Product and Services
Table 38. Agilent Technologies Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Agilent Technologies Recent Developments/Updates
Table 40. Agilent Technologies Competitive Strengths & Weaknesses
Table 41. Illumina Basic Information, Area Served and Competitors
Table 42. Illumina Major Business
Table 43. Illumina Clinical Next Generation Sequencing (NGS) Product and Services
Table 44. Illumina Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Illumina Recent Developments/Updates
Table 46. Illumina Competitive Strengths & Weaknesses
Table 47. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 48. Thermo Fisher Scientific Major Business
Table 49. Thermo Fisher Scientific Clinical Next Generation Sequencing (NGS) Product and Services
Table 50. Thermo Fisher Scientific Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Thermo Fisher Scientific Recent Developments/Updates
Table 52. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 53. Eurofins Scientific Basic Information, Area Served and Competitors
Table 54. Eurofins Scientific Major Business
Table 55. Eurofins Scientific Clinical Next Generation Sequencing (NGS) Product and Services
Table 56. Eurofins Scientific Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Eurofins Scientific Recent Developments/Updates
Table 58. Eurofins Scientific Competitive Strengths & Weaknesses
Table 59. BGI Group Basic Information, Area Served and Competitors
Table 60. BGI Group Major Business
Table 61. BGI Group Clinical Next Generation Sequencing (NGS) Product and Services
Table 62. BGI Group Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. BGI Group Recent Developments/Updates
Table 64. BGI Group Competitive Strengths & Weaknesses
Table 65. Qiagen Basic Information, Area Served and Competitors
Table 66. Qiagen Major Business
Table 67. Qiagen Clinical Next Generation Sequencing (NGS) Product and Services
Table 68. Qiagen Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Qiagen Recent Developments/Updates
Table 70. Qiagen Competitive Strengths & Weaknesses
Table 71. Roche Diagnostics Basic Information, Area Served and Competitors
Table 72. Roche Diagnostics Major Business
Table 73. Roche Diagnostics Clinical Next Generation Sequencing (NGS) Product and Services
Table 74. Roche Diagnostics Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Roche Diagnostics Recent Developments/Updates
Table 76. Roche Diagnostics Competitive Strengths & Weaknesses
Table 77. Bio-Rad Basic Information, Area Served and Competitors
Table 78. Bio-Rad Major Business
Table 79. Bio-Rad Clinical Next Generation Sequencing (NGS) Product and Services
Table 80. Bio-Rad Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Bio-Rad Recent Developments/Updates
Table 82. Bio-Rad Competitive Strengths & Weaknesses
Table 83. Congenica Basic Information, Area Served and Competitors
Table 84. Congenica Major Business
Table 85. Congenica Clinical Next Generation Sequencing (NGS) Product and Services
Table 86. Congenica Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Congenica Recent Developments/Updates
Table 88. Congenica Competitive Strengths & Weaknesses
Table 89. Theragen Etex Basic Information, Area Served and Competitors
Table 90. Theragen Etex Major Business
Table 91. Theragen Etex Clinical Next Generation Sequencing (NGS) Product and Services
Table 92. Theragen Etex Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Theragen Etex Recent Developments/Updates
Table 94. Theragen Etex Competitive Strengths & Weaknesses
Table 95. PerkinElmer Basic Information, Area Served and Competitors
Table 96. PerkinElmer Major Business
Table 97. PerkinElmer Clinical Next Generation Sequencing (NGS) Product and Services
Table 98. PerkinElmer Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. PerkinElmer Recent Developments/Updates
Table 100. PerkinElmer Competitive Strengths & Weaknesses
Table 101. Partek Basic Information, Area Served and Competitors
Table 102. Partek Major Business
Table 103. Partek Clinical Next Generation Sequencing (NGS) Product and Services
Table 104. Partek Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Partek Recent Developments/Updates
Table 106. Partek Competitive Strengths & Weaknesses
Table 107. Oxford Nanopore Technologies Basic Information, Area Served and Competitors
Table 108. Oxford Nanopore Technologies Major Business
Table 109. Oxford Nanopore Technologies Clinical Next Generation Sequencing (NGS) Product and Services
Table 110. Oxford Nanopore Technologies Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Oxford Nanopore Technologies Recent Developments/Updates
Table 112. Oxford Nanopore Technologies Competitive Strengths & Weaknesses
Table 113. Pacific Biosciences of California Basic Information, Area Served and Competitors
Table 114. Pacific Biosciences of California Major Business
Table 115. Pacific Biosciences of California Clinical Next Generation Sequencing (NGS) Product and Services
Table 116. Pacific Biosciences of California Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Pacific Biosciences of California Recent Developments/Updates
Table 118. Pacific Biosciences of California Competitive Strengths & Weaknesses
Table 119. Golden Helix Basic Information, Area Served and Competitors
Table 120. Golden Helix Major Business
Table 121. Golden Helix Clinical Next Generation Sequencing (NGS) Product and Services
Table 122. Golden Helix Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Golden Helix Recent Developments/Updates
Table 124. Golden Helix Competitive Strengths & Weaknesses
Table 125. BioDatomics Basic Information, Area Served and Competitors
Table 126. BioDatomics Major Business
Table 127. BioDatomics Clinical Next Generation Sequencing (NGS) Product and Services
Table 128. BioDatomics Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. BioDatomics Recent Developments/Updates
Table 130. BioDatomics Competitive Strengths & Weaknesses
Table 131. PierianDx Basic Information, Area Served and Competitors
Table 132. PierianDx Major Business
Table 133. PierianDx Clinical Next Generation Sequencing (NGS) Product and Services
Table 134. PierianDx Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. PierianDx Recent Developments/Updates
Table 136. DNAStar Basic Information, Area Served and Competitors
Table 137. DNAStar Major Business
Table 138. DNAStar Clinical Next Generation Sequencing (NGS) Product and Services
Table 139. DNAStar Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 140. Global Key Players of Clinical Next Generation Sequencing (NGS) Upstream (Raw Materials)
Table 141. Clinical Next Generation Sequencing (NGS) Typical Customers
LIST OF FIGURES
Figure 1. Clinical Next Generation Sequencing (NGS) Picture
Figure 2. World Clinical Next Generation Sequencing (NGS) Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Clinical Next Generation Sequencing (NGS) Total Market Size (2018-2029) & (USD Million)
Figure 4. World Clinical Next Generation Sequencing (NGS) Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Clinical Next Generation Sequencing (NGS) Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Clinical Next Generation Sequencing (NGS) Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Clinical Next Generation Sequencing (NGS) Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Clinical Next Generation Sequencing (NGS) Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Clinical Next Generation Sequencing (NGS) Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Clinical Next Generation Sequencing (NGS) Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Clinical Next Generation Sequencing (NGS) Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Clinical Next Generation Sequencing (NGS) Revenue (2018-2029) & (USD Million)
Figure 13. Clinical Next Generation Sequencing (NGS) Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029) & (USD Million)
Figure 16. World Clinical Next Generation Sequencing (NGS) Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029) & (USD Million)
Figure 18. China Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029) & (USD Million)
Figure 23. India Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Clinical Next Generation Sequencing (NGS) by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Clinical Next Generation Sequencing (NGS) Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Clinical Next Generation Sequencing (NGS) Markets in 2022
Figure 27. United States VS China: Clinical Next Generation Sequencing (NGS) Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Clinical Next Generation Sequencing (NGS) Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Clinical Next Generation Sequencing (NGS) Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Clinical Next Generation Sequencing (NGS) Market Size Market Share by Type in 2022
Figure 31. Sequencing by Synthesis (SBS)
Figure 32. Nanopore Sequencing
Figure 33. Single-Molecule Real-Time (SMRT) Sequencing
Figure 34. Others
Figure 35. World Clinical Next Generation Sequencing (NGS) Market Size Market Share by Type (2018-2029)
Figure 36. World Clinical Next Generation Sequencing (NGS) Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World Clinical Next Generation Sequencing (NGS) Market Size Market Share by Application in 2022
Figure 38. Diagnostics
Figure 39. Drug Discovery & Designing
Figure 40. Medical Research
Figure 41. Others
Figure 42. Clinical Next Generation Sequencing (NGS) Industrial Chain
Figure 43. Methodology
Figure 44. Research Process and Data Source
Figure 1. Clinical Next Generation Sequencing (NGS) Picture
Figure 2. World Clinical Next Generation Sequencing (NGS) Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Clinical Next Generation Sequencing (NGS) Total Market Size (2018-2029) & (USD Million)
Figure 4. World Clinical Next Generation Sequencing (NGS) Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Clinical Next Generation Sequencing (NGS) Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Clinical Next Generation Sequencing (NGS) Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Clinical Next Generation Sequencing (NGS) Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Clinical Next Generation Sequencing (NGS) Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Clinical Next Generation Sequencing (NGS) Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Clinical Next Generation Sequencing (NGS) Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Clinical Next Generation Sequencing (NGS) Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Clinical Next Generation Sequencing (NGS) Revenue (2018-2029) & (USD Million)
Figure 13. Clinical Next Generation Sequencing (NGS) Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029) & (USD Million)
Figure 16. World Clinical Next Generation Sequencing (NGS) Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029) & (USD Million)
Figure 18. China Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029) & (USD Million)
Figure 23. India Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Clinical Next Generation Sequencing (NGS) by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Clinical Next Generation Sequencing (NGS) Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Clinical Next Generation Sequencing (NGS) Markets in 2022
Figure 27. United States VS China: Clinical Next Generation Sequencing (NGS) Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Clinical Next Generation Sequencing (NGS) Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Clinical Next Generation Sequencing (NGS) Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Clinical Next Generation Sequencing (NGS) Market Size Market Share by Type in 2022
Figure 31. Sequencing by Synthesis (SBS)
Figure 32. Nanopore Sequencing
Figure 33. Single-Molecule Real-Time (SMRT) Sequencing
Figure 34. Others
Figure 35. World Clinical Next Generation Sequencing (NGS) Market Size Market Share by Type (2018-2029)
Figure 36. World Clinical Next Generation Sequencing (NGS) Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World Clinical Next Generation Sequencing (NGS) Market Size Market Share by Application in 2022
Figure 38. Diagnostics
Figure 39. Drug Discovery & Designing
Figure 40. Medical Research
Figure 41. Others
Figure 42. Clinical Next Generation Sequencing (NGS) Industrial Chain
Figure 43. Methodology
Figure 44. Research Process and Data Source
